CASE REPORT


Dorsal Root Ganglion Stimulation for the Management of Chronic Neuropathic Pain: A Retrospective Case Series during Four Years follow-up in a Single Center



Alfonso Papa1, *, Elisabetta Saracco1, Maria Teresa Di Dato1, Pietro Buonavolontà1, Anna Maria Salzano1, Dario Tammaro1, Beniamino Casale1
1 Department of Pain - Azienda Ospedaliera Dei Colli, Monaldi Hospital, Napoli, Italy


Article Metrics

CrossRef Citations:
1
Total Statistics:

Full-Text HTML Views: 2416
Abstract HTML Views: 904
PDF Downloads: 669
ePub Downloads: 321
Total Views/Downloads: 4310
Unique Statistics:

Full-Text HTML Views: 1215
Abstract HTML Views: 437
PDF Downloads: 466
ePub Downloads: 158
Total Views/Downloads: 2276



Creative Commons License
© 2020 Papa et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at Department of Pain - Azienda Ospedaliera Dei Colli, Monaldi Hospital, Via Leonardo Bianchi,1 – 80131 Napoli, Italy; Tel: +39-081-7064137; Fax: +39-081-7062932; E-mail: alfonsopapa@libero.it


Abstract

Objectives:

The dorsal root ganglion (DRG) is involved in the transduction of pain signals to the central nervous system (CNS) and undergoes a number of physiopathological changes during chronic pain. The purpose of this data collection was to evaluate the long-term safety and efficacy of DRG stimulation for the treatment of chronic pain and its impact on functional aspects.

Materials and Methods:

Forty-four subjects with non-reactive chronic neuropathic pain syndrome were implanted with DRG stimulation.

Patients were evaluated at baseline as well as at 15, and 30 days, and at 3, 6, 12, 24, 36 and 48 months after medical intervention/surgery using the Visual Analogic Scale (VAS), which measures pain intensity, and the Oswestry Scale, for the estimation of disability (ODI).

Results:

After four years of simulation, VAS and ODI showed a statistically significant reduction throughout the follow-up period. The average pain relief obtained after 48 months of treatment was 74.1% ± 3.4.

Conclusion:

The results of this data collection demonstrate the feasibility of DRG stimulation, the correspondence between the clinical indications at the DRG implant and what is commonly found in the literature on this technique.(18,20) Patients defined as clinical responders to DRG stimulation and so implanted with definitive IPG showed a sustained and long term efficacy. Eight patients had previously been implanted with a traditional SCS without any clinically relevant efficacy; they were then explained for unsatisfactory results. Six of them (75%) were later implanted with DRG, with long-term effectiveness. Another advantage of this therapy is the absence of positional effects and lead migration. The adverse events proved to be independent of the anatomical level of insertion; moreover, this series of cases show a lower incidence of lead migration than reported in the literature. In summary, DRGs have been ignored for too long, probably due to the technical difficulty of reaching their deep, almost extra-spinal anatomical position.

Keywords: Chronic pain, Dorsal root ganglion (DRG), Spinal cord stimulation (SCS), Visual analog scale (VAS), Extra-spinal anatomical position, Anatomical level of insertion.